Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sale of Vitamin B and Its Related Products	623.97M	638.80M	737.82M	797.64M	785.57M
Production and Sale of Vitamin B and Its Related Products Growth	-2.32%	-13.42%	-7.50%	1.54%	14.15%
Total	623.97M	638.80M	737.82M	797.64M	785.57M
Total Growth	-2.32%	-13.42%	-7.50%	1.54%	14.15%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
domestic	404.97M	388.70M	555.69M	580.84M	479.81M
domestic Growth	4.19%	-30.05%	-4.33%	21.06%	14.83%
Foreign	219.00M	250.10M	182.13M	216.80M	305.77M
Foreign Growth	-12.43%	37.32%	-15.99%	-29.10%	13.11%
Total	623.97M	638.80M	737.82M	797.64M	785.57M
Total Growth	-2.32%	-13.42%	-7.50%	1.54%	14.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error